Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00QUZ
|
||||
| Former ID |
DIB008874
|
||||
| Drug Name |
TTP-814
|
||||
| Synonyms |
PTP-1B inhibitors (oral, type 2 diabetes), TransTech Pharma
|
||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Phase 1/2 | [548015] | ||
| Company |
TransTech Pharma Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [551204] | |
| KEGG Pathway | Adherens junction | ||||
| Insulin signaling pathway | |||||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Cadherin signaling pathway | ||||
| Pathway Interaction Database | Insulin Pathway | ||||
| Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
| Signaling events mediated by PTP1B | |||||
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
| Signaling events mediated by TCPTP | |||||
| IGF1 pathway | |||||
| EGF receptor (ErbB1) signaling pathway | |||||
| Posttranslational regulation of adherens junction stability and dissassembly | |||||
| PDGFR-beta signaling pathway | |||||
| N-cadherin signaling events | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.